Displacement of One Drug by Another from Carrier or Receptor Sites
Open Access
- 1 November 1965
- journal article
- abstracts
- Published by SAGE Publications in Proceedings of the Royal Society of Medicine
- Vol. 58 (11P2), 946-955
- https://doi.org/10.1177/003591576505811p202
Abstract
The medium of drug transfer is the water of plasma and extracellular fluid. Without complicating factors, the level of drug at a receptor site would be equal to that in the tissues and in plasma, and in dynamic equilibrium. Actually, almost all drugs are reversibly bound to proteins in plasma or tissue. The bound drug, often a high proportion of the total, acts as a reservoir, preventing wild fluctuations between ineffective and toxic levels of the biologically active unbound fraction. Displacement from a receptor site diminishes drug activity, but displacement from plasma or tissue proteins augments the effect by making more unbound drug available at the receptor site. Atropine has no intrinsic activity, but displaces acetylcholine or pilocarpine from receptors at para-sympathetic nerve endings. Similarly guanethidine competes with noradrenaline at sympathetic nerve endings, but in turn is displaced by amphetamine-like drugs. Many acidic drugs (phenylbutazone, sulfonamides, coumarin anticoagulants, salicylates, &c.) are highly bound to one or two sites on albumin molecules. When the limited carrying capacity of the plasma proteins is filled, any unbound surplus is usually soon metabolized or excreted, so the plasma level becomes restabilized. Meanwhile, however, there may be dramatic effects such as hypoglycemia, when sulfonamides are given to patients on tolbutamide, or bleeding when phenylbutazone is given to patients on warfarin. Although hormones, like thyroxine, insulin and cortisol, are carried by specific proteins, they too can be displaced. All the antirheumatic drugs so far examined have displaced cortisol and presumably driven it into tissues. This may be one mechanism of action. Possibly the sulfonylurea drugs act by displacing insulin from proteins in the pancreas, plasma or elsewhere.Keywords
This publication has 11 references indexed in Scilit:
- Pharmacology and Mode of Action of the Hypoglycaemic Sulphonylureas and DiguanidesAnnual Review of Pharmacology, 1965
- Physiological disposition of guanethidine in the rat and its uptake by heart slicesInternational Journal of Neuropharmacology, 1965
- Reserpine-induced release of drugs from sympathetic nerve endingsLife Sciences, 1964
- Combined Effect of Sodium Warfarin and PhenylbutazonePublished by American Medical Association (AMA) ,1964
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963
- STUDIES IN KERNICTERUS. I. THE PROTEIN BINDING OF BILIRUBIN*JCI Insight, 1959
- BINDING OF CORTICOSTEROIDS BY PLASMA PROTEINS. III. THE BINDING OF CORTICOSTEROID AND RELATED HORMONES BY HUMAN PLASMA AND PLASMA PROTEIN FRACTIONS AS MEASURED BY EQUILIBRIUM DIALYSIS12JCI Insight, 1958
- BINDING OF CORTICOSTEROIDS BY PLASMA PROTEINS. I. DIALYSIS EQUILIBRIUM AND RENAL CLEARANCE STUDIES 12JCI Insight, 1956
- THE REVERSIBILITY OF CERTAIN RHEUMATIC AND NONRHEUMATIC CONDITIONS BY THE USE OF CORTISONE OR OF THE PITUITARY ADRENOCORTICOTROPIC HORMONEAnnals of Internal Medicine, 1952
- STUDIES ON THE CHEMOTHERAPY OF THE HUMAN MALARIAS. VIII. THE PHYSIOLOGICAL DISPOSITION OF PAMAQUINE 123JCI Insight, 1948